ZAI LAB (09688.HK) saw its stock price soar by 6.63% in intraday trading on Wednesday, as part of a broader rally in Hong Kong's pharmaceutical sector. The significant uptick in ZAI LAB's share price reflects the strong performance seen across multiple pharmaceutical companies listed on the Hong Kong stock exchange.

The pharmaceutical sector in Hong Kong experienced a notable surge, with several key players posting substantial gains. Innovent Biologics led the pack with an impressive 15% increase, while other major pharmaceutical companies also saw significant upticks. Junshi Biosciences and CSPC Pharmaceutical Group both rose by 4%, while Tigermed Consulting and Innocare Pharma each gained 3%.

While no specific news was reported for ZAI LAB, the company's strong performance appears to be riding on the wave of positive sentiment surrounding the Hong Kong pharmaceutical sector. Investors seem to be showing renewed interest in pharmaceutical stocks, possibly due to sector-wide developments or macroeconomic factors affecting the industry as a whole. As always, investors are advised to conduct their own research and consider market trends when making investment decisions.